Skip to main content

Briacell Therapeutics Corp(BCT-T)
TSX

Today's Change
Real-Time Last Update

Briacell Therapeutics Corp

235-15th Street
Suite 300, 3rd Floor, Bellevue Centre
Vancouver BC V7T 2X1 CAN
P: 888-485-6340
F: 424-245-3719
https://www.briacell.com

Profile

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Key Executives

NameTitle
Gadi LevinCFO/Chief Accounting Officer/Secretary
William V. WilliamsCEO/Director/President
Miguel A. Lopez-LagoChief Scientific Officer
Giuseppe Del PrioreChief Medical Officer

More from The Globe

Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in Toronto is photographed on Friday, November 11, 2022.
Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.
Thursday’s analyst upgrades and downgrades
A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024.
Wednesday’s analyst upgrades and downgrades
A Pet Valu store is pictured in Ottawa, Tuesday, Sept. 13, 2022.
number cruncher
Seven Canadian oil producers set to benefit from rising prices
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Mullen Group Ltd.
Monica Rizk
Top non-resource stocks on the TSX with strong insider signals
Ted Dixon
Berkshire Hathaway shares have largest slide since Buffett’s resignation
FILE PHOTO: A screen displays the trading information for Berkshire Hathaway inc. as traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 22, 2025. REUTERS/Brendan McDermid/File Photo

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.